Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

CELTRIX UNDERWRITERS EXERCISE OPTION

Aug. 20, 1991

INTERNEURON DEAL FOR ALZHEIMER'S DRUG

Aug. 20, 1991

FDA SEIZES COLLAGEN PRODUCTS

Aug. 19, 1991

AMGEN GETS $25M LIEN AGAINST GI

Aug. 19, 1991

INNOVET GRANTS RIGHTS TO BIO-POLYMER SYSTEM

Aug. 19, 1991

CALGENE TO FOCUS ON CORE CROPS

Aug. 19, 1991

APPOINTMENTS AND ADVANCEMENTS

Aug. 19, 1991

MIMETICS MAY HERALD A NEW CLASS OF DRUGS

Aug. 16, 1991

ANALYST RECOMMENDS TAKING PROFITS ON ICOS

Aug. 16, 1991

KODAK SEEKS INJUNCTION AGAINST CETUS

Aug. 16, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...